Treatment with omalizumab offers modest protection from allergic reactions to individuals with multiple food allergies, and ...
Immunome stock surges after positive results from Phase 3 trial for desmoid tumors, meeting all key endpoints.
Recurrent or metastatic nasopharyngeal carcinoma is an aggressive disease, and long-term survival with chemotherapy alone is ...
Varegacestat, an investigational gamma secretase inhibitor (GSI), delivered clinically meaningful improvements in efficacy ...
When teams treat AI as a tool for insight rather than full automation, and keep human judgment at the center, adoption ...
Lunit Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Translational Oncology ...
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted ...
Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.
Study Finds on MSN
Cell-Sized Robots Can Sense, Decide, and Move Without Outside Control
Cell-sized robots can sense temperature, make decisions, and move autonomously using nanowatts of power—no external control ...
Findings provide scientific insights into the contributions of IDO1 and PD-L1 vaccination to PD-1 blockade for the treatment of metastatic melanomaFive-year analysis of median progression free ...
MedPage Today on MSN
Preop RT May Boost Response to Chemo-Immunotherapy in High-Risk Early Breast Cancer
SAN ANTONIO -- Preoperative radiotherapy (RT) plus PD-1 inhibitor pembrolizumab (Keytruda) significantly increased immune ...
The FDA has approved Uplizna for generalized myasthenia gravis in adults who are anti-AChR and anti-MuSK antibody positive.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback